chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: LYME
Symptoms: Cognitive disorder, Decreased activity, Disturbance in attention, Fatigue, Full blood count normal
Clinical narrative: This case was reported by a lawyer and described the occurrence of numbness in a female subject of unspecified age who was vaccinated with LYMErix for prophylaxis. A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of LYMErix (unknown). An unspecified time after vaccination with LYMErix, the subject experienced numbness, tingling, fatigue, body pain, autoimmune disease, activities of daily living impaired, facial twitching, memory loss, arthralgia, head vibrating, migraine, myalgia, rash, muscle spasm, poor concentration, stiffness, rheumatological symptoms, neurological impairment, cognitive impairment and decreased activity level. At the time of reporting the outcome of the events were unspecified. The information in this case was receiving via a Statement of Injuries. Follow up information was received on 09 April 2007 via medical records. The subject was a female in her twenties at the time of vaccination with LYMErix. On 06 January 2006 radiologic examination of the brain was performed for an indication of "Lyme" and showed mildly decreased cortical perfusion. It was noted that findings were consistent with "Lyme disease, vasculitis, or medication side effects". On 27 March 2006, testing was positive for Lyme (IgM, Western Blot). The subject was evaluated on 25 October 2006 for Lyme disease. According to the subject's report, she had been in good health, and developed a rash in 1998 or 1999. She was told that she was negative for Lyme disease, and was vaccinated with LYMErix. Following vaccination, she developed a stiff neck and spin, numbness, burning, pins and needles, decreased memory and "word search", and body twitching. She had previously received doxycycline, which helped her symptoms. A history of "neurological Lyme, ? (multiple sclerosis), peripheral neuropathy" was noted. Upon evaluation, the subject endorsed fatigue, memory changes, paraesthesia of the hands and toes, myalgias of the neck and back, and arthralgias. Additional complaints included heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocuturia. On 27 November 2006, assessment included Lyme disease, and treatment with Bicillin was initiated. This case was assessed to be medically significant by manufacturer based upon follow up information. The subject complained of heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocturia. In November 2006 she was diagnosed with a urinary tract infection. These were considered to be incidental findings upon medical record review.
Age: 34.0
Sex: F
Vaccine: LYME
Symptoms: Head discomfort, Hypoaesthesia, Immunology test, Insomnia, Lyme disease
Clinical narrative: This case was reported by a lawyer and described the occurrence of numbness in a female subject of unspecified age who was vaccinated with LYMErix for prophylaxis. A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of LYMErix (unknown). An unspecified time after vaccination with LYMErix, the subject experienced numbness, tingling, fatigue, body pain, autoimmune disease, activities of daily living impaired, facial twitching, memory loss, arthralgia, head vibrating, migraine, myalgia, rash, muscle spasm, poor concentration, stiffness, rheumatological symptoms, neurological impairment, cognitive impairment and decreased activity level. At the time of reporting the outcome of the events were unspecified. The information in this case was receiving via a Statement of Injuries. Follow up information was received on 09 April 2007 via medical records. The subject was a female in her twenties at the time of vaccination with LYMErix. On 06 January 2006 radiologic examination of the brain was performed for an indication of "Lyme" and showed mildly decreased cortical perfusion. It was noted that findings were consistent with "Lyme disease, vasculitis, or medication side effects". On 27 March 2006, testing was positive for Lyme (IgM, Western Blot). The subject was evaluated on 25 October 2006 for Lyme disease. According to the subject's report, she had been in good health, and developed a rash in 1998 or 1999. She was told that she was negative for Lyme disease, and was vaccinated with LYMErix. Following vaccination, she developed a stiff neck and spin, numbness, burning, pins and needles, decreased memory and "word search", and body twitching. She had previously received doxycycline, which helped her symptoms. A history of "neurological Lyme, ? (multiple sclerosis), peripheral neuropathy" was noted. Upon evaluation, the subject endorsed fatigue, memory changes, paraesthesia of the hands and toes, myalgias of the neck and back, and arthralgias. Additional complaints included heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocuturia. On 27 November 2006, assessment included Lyme disease, and treatment with Bicillin was initiated. This case was assessed to be medically significant by manufacturer based upon follow up information. The subject complained of heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocturia. In November 2006 she was diagnosed with a urinary tract infection. These were considered to be incidental findings upon medical record review.
Age: 34.0
Sex: F
Vaccine: LYME
Symptoms: Lymphocyte count normal, Memory impairment, Metabolic function test normal, Migraine, Multiple sclerosis
Clinical narrative: This case was reported by a lawyer and described the occurrence of numbness in a female subject of unspecified age who was vaccinated with LYMErix for prophylaxis. A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of LYMErix (unknown). An unspecified time after vaccination with LYMErix, the subject experienced numbness, tingling, fatigue, body pain, autoimmune disease, activities of daily living impaired, facial twitching, memory loss, arthralgia, head vibrating, migraine, myalgia, rash, muscle spasm, poor concentration, stiffness, rheumatological symptoms, neurological impairment, cognitive impairment and decreased activity level. At the time of reporting the outcome of the events were unspecified. The information in this case was receiving via a Statement of Injuries. Follow up information was received on 09 April 2007 via medical records. The subject was a female in her twenties at the time of vaccination with LYMErix. On 06 January 2006 radiologic examination of the brain was performed for an indication of "Lyme" and showed mildly decreased cortical perfusion. It was noted that findings were consistent with "Lyme disease, vasculitis, or medication side effects". On 27 March 2006, testing was positive for Lyme (IgM, Western Blot). The subject was evaluated on 25 October 2006 for Lyme disease. According to the subject's report, she had been in good health, and developed a rash in 1998 or 1999. She was told that she was negative for Lyme disease, and was vaccinated with LYMErix. Following vaccination, she developed a stiff neck and spin, numbness, burning, pins and needles, decreased memory and "word search", and body twitching. She had previously received doxycycline, which helped her symptoms. A history of "neurological Lyme, ? (multiple sclerosis), peripheral neuropathy" was noted. Upon evaluation, the subject endorsed fatigue, memory changes, paraesthesia of the hands and toes, myalgias of the neck and back, and arthralgias. Additional complaints included heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocuturia. On 27 November 2006, assessment included Lyme disease, and treatment with Bicillin was initiated. This case was assessed to be medically significant by manufacturer based upon follow up information. The subject complained of heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocturia. In November 2006 she was diagnosed with a urinary tract infection. These were considered to be incidental findings upon medical record review.
Age: 34.0
Sex: F
Vaccine: LYME
Symptoms: Muscle spasms, Muscle twitching, Musculoskeletal pain, Musculoskeletal stiffness, Myalgia
Clinical narrative: This case was reported by a lawyer and described the occurrence of numbness in a female subject of unspecified age who was vaccinated with LYMErix for prophylaxis. A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of LYMErix (unknown). An unspecified time after vaccination with LYMErix, the subject experienced numbness, tingling, fatigue, body pain, autoimmune disease, activities of daily living impaired, facial twitching, memory loss, arthralgia, head vibrating, migraine, myalgia, rash, muscle spasm, poor concentration, stiffness, rheumatological symptoms, neurological impairment, cognitive impairment and decreased activity level. At the time of reporting the outcome of the events were unspecified. The information in this case was receiving via a Statement of Injuries. Follow up information was received on 09 April 2007 via medical records. The subject was a female in her twenties at the time of vaccination with LYMErix. On 06 January 2006 radiologic examination of the brain was performed for an indication of "Lyme" and showed mildly decreased cortical perfusion. It was noted that findings were consistent with "Lyme disease, vasculitis, or medication side effects". On 27 March 2006, testing was positive for Lyme (IgM, Western Blot). The subject was evaluated on 25 October 2006 for Lyme disease. According to the subject's report, she had been in good health, and developed a rash in 1998 or 1999. She was told that she was negative for Lyme disease, and was vaccinated with LYMErix. Following vaccination, she developed a stiff neck and spin, numbness, burning, pins and needles, decreased memory and "word search", and body twitching. She had previously received doxycycline, which helped her symptoms. A history of "neurological Lyme, ? (multiple sclerosis), peripheral neuropathy" was noted. Upon evaluation, the subject endorsed fatigue, memory changes, paraesthesia of the hands and toes, myalgias of the neck and back, and arthralgias. Additional complaints included heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocuturia. On 27 November 2006, assessment included Lyme disease, and treatment with Bicillin was initiated. This case was assessed to be medically significant by manufacturer based upon follow up information. The subject complained of heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocturia. In November 2006 she was diagnosed with a urinary tract infection. These were considered to be incidental findings upon medical record review.
Age: 34.0
Sex: F
Vaccine: LYME
Symptoms: Nervous system disorder, Neuropathy peripheral, Nocturia, Pain, Palpitations
Clinical narrative: This case was reported by a lawyer and described the occurrence of numbness in a female subject of unspecified age who was vaccinated with LYMErix for prophylaxis. A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of LYMErix (unknown). An unspecified time after vaccination with LYMErix, the subject experienced numbness, tingling, fatigue, body pain, autoimmune disease, activities of daily living impaired, facial twitching, memory loss, arthralgia, head vibrating, migraine, myalgia, rash, muscle spasm, poor concentration, stiffness, rheumatological symptoms, neurological impairment, cognitive impairment and decreased activity level. At the time of reporting the outcome of the events were unspecified. The information in this case was receiving via a Statement of Injuries. Follow up information was received on 09 April 2007 via medical records. The subject was a female in her twenties at the time of vaccination with LYMErix. On 06 January 2006 radiologic examination of the brain was performed for an indication of "Lyme" and showed mildly decreased cortical perfusion. It was noted that findings were consistent with "Lyme disease, vasculitis, or medication side effects". On 27 March 2006, testing was positive for Lyme (IgM, Western Blot). The subject was evaluated on 25 October 2006 for Lyme disease. According to the subject's report, she had been in good health, and developed a rash in 1998 or 1999. She was told that she was negative for Lyme disease, and was vaccinated with LYMErix. Following vaccination, she developed a stiff neck and spin, numbness, burning, pins and needles, decreased memory and "word search", and body twitching. She had previously received doxycycline, which helped her symptoms. A history of "neurological Lyme, ? (multiple sclerosis), peripheral neuropathy" was noted. Upon evaluation, the subject endorsed fatigue, memory changes, paraesthesia of the hands and toes, myalgias of the neck and back, and arthralgias. Additional complaints included heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocuturia. On 27 November 2006, assessment included Lyme disease, and treatment with Bicillin was initiated. This case was assessed to be medically significant by manufacturer based upon follow up information. The subject complained of heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocturia. In November 2006 she was diagnosed with a urinary tract infection. These were considered to be incidental findings upon medical record review.
Age: 34.0
Sex: F
Vaccine: LYME
Symptoms: Paraesthesia, Platelet count normal, Pollakiuria, Poor peripheral circulation, Rash
Clinical narrative: This case was reported by a lawyer and described the occurrence of numbness in a female subject of unspecified age who was vaccinated with LYMErix for prophylaxis. A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of LYMErix (unknown). An unspecified time after vaccination with LYMErix, the subject experienced numbness, tingling, fatigue, body pain, autoimmune disease, activities of daily living impaired, facial twitching, memory loss, arthralgia, head vibrating, migraine, myalgia, rash, muscle spasm, poor concentration, stiffness, rheumatological symptoms, neurological impairment, cognitive impairment and decreased activity level. At the time of reporting the outcome of the events were unspecified. The information in this case was receiving via a Statement of Injuries. Follow up information was received on 09 April 2007 via medical records. The subject was a female in her twenties at the time of vaccination with LYMErix. On 06 January 2006 radiologic examination of the brain was performed for an indication of "Lyme" and showed mildly decreased cortical perfusion. It was noted that findings were consistent with "Lyme disease, vasculitis, or medication side effects". On 27 March 2006, testing was positive for Lyme (IgM, Western Blot). The subject was evaluated on 25 October 2006 for Lyme disease. According to the subject's report, she had been in good health, and developed a rash in 1998 or 1999. She was told that she was negative for Lyme disease, and was vaccinated with LYMErix. Following vaccination, she developed a stiff neck and spin, numbness, burning, pins and needles, decreased memory and "word search", and body twitching. She had previously received doxycycline, which helped her symptoms. A history of "neurological Lyme, ? (multiple sclerosis), peripheral neuropathy" was noted. Upon evaluation, the subject endorsed fatigue, memory changes, paraesthesia of the hands and toes, myalgias of the neck and back, and arthralgias. Additional complaints included heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocuturia. On 27 November 2006, assessment included Lyme disease, and treatment with Bicillin was initiated. This case was assessed to be medically significant by manufacturer based upon follow up information. The subject complained of heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocturia. In November 2006 she was diagnosed with a urinary tract infection. These were considered to be incidental findings upon medical record review.
Age: 34.0
Sex: F
Vaccine: LYME
Symptoms: Red blood cell sedimentation rate normal, Scan brain, Thinking abnormal, Urinary tract infection, Vasculitis
Clinical narrative: This case was reported by a lawyer and described the occurrence of numbness in a female subject of unspecified age who was vaccinated with LYMErix for prophylaxis. A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of LYMErix (unknown). An unspecified time after vaccination with LYMErix, the subject experienced numbness, tingling, fatigue, body pain, autoimmune disease, activities of daily living impaired, facial twitching, memory loss, arthralgia, head vibrating, migraine, myalgia, rash, muscle spasm, poor concentration, stiffness, rheumatological symptoms, neurological impairment, cognitive impairment and decreased activity level. At the time of reporting the outcome of the events were unspecified. The information in this case was receiving via a Statement of Injuries. Follow up information was received on 09 April 2007 via medical records. The subject was a female in her twenties at the time of vaccination with LYMErix. On 06 January 2006 radiologic examination of the brain was performed for an indication of "Lyme" and showed mildly decreased cortical perfusion. It was noted that findings were consistent with "Lyme disease, vasculitis, or medication side effects". On 27 March 2006, testing was positive for Lyme (IgM, Western Blot). The subject was evaluated on 25 October 2006 for Lyme disease. According to the subject's report, she had been in good health, and developed a rash in 1998 or 1999. She was told that she was negative for Lyme disease, and was vaccinated with LYMErix. Following vaccination, she developed a stiff neck and spin, numbness, burning, pins and needles, decreased memory and "word search", and body twitching. She had previously received doxycycline, which helped her symptoms. A history of "neurological Lyme, ? (multiple sclerosis), peripheral neuropathy" was noted. Upon evaluation, the subject endorsed fatigue, memory changes, paraesthesia of the hands and toes, myalgias of the neck and back, and arthralgias. Additional complaints included heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocuturia. On 27 November 2006, assessment included Lyme disease, and treatment with Bicillin was initiated. This case was assessed to be medically significant by manufacturer based upon follow up information. The subject complained of heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocturia. In November 2006 she was diagnosed with a urinary tract infection. These were considered to be incidental findings upon medical record review.
Age: 34.0
Sex: F
Vaccine: LYME
Symptoms: Vitamin B12, Vitamin D
Clinical narrative: This case was reported by a lawyer and described the occurrence of numbness in a female subject of unspecified age who was vaccinated with LYMErix for prophylaxis. A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of LYMErix (unknown). An unspecified time after vaccination with LYMErix, the subject experienced numbness, tingling, fatigue, body pain, autoimmune disease, activities of daily living impaired, facial twitching, memory loss, arthralgia, head vibrating, migraine, myalgia, rash, muscle spasm, poor concentration, stiffness, rheumatological symptoms, neurological impairment, cognitive impairment and decreased activity level. At the time of reporting the outcome of the events were unspecified. The information in this case was receiving via a Statement of Injuries. Follow up information was received on 09 April 2007 via medical records. The subject was a female in her twenties at the time of vaccination with LYMErix. On 06 January 2006 radiologic examination of the brain was performed for an indication of "Lyme" and showed mildly decreased cortical perfusion. It was noted that findings were consistent with "Lyme disease, vasculitis, or medication side effects". On 27 March 2006, testing was positive for Lyme (IgM, Western Blot). The subject was evaluated on 25 October 2006 for Lyme disease. According to the subject's report, she had been in good health, and developed a rash in 1998 or 1999. She was told that she was negative for Lyme disease, and was vaccinated with LYMErix. Following vaccination, she developed a stiff neck and spin, numbness, burning, pins and needles, decreased memory and "word search", and body twitching. She had previously received doxycycline, which helped her symptoms. A history of "neurological Lyme, ? (multiple sclerosis), peripheral neuropathy" was noted. Upon evaluation, the subject endorsed fatigue, memory changes, paraesthesia of the hands and toes, myalgias of the neck and back, and arthralgias. Additional complaints included heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocuturia. On 27 November 2006, assessment included Lyme disease, and treatment with Bicillin was initiated. This case was assessed to be medically significant by manufacturer based upon follow up information. The subject complained of heart palpitations, poor circulation, insomnia, menstrual cramps, urinary frequency, and nocturia. In November 2006 she was diagnosed with a urinary tract infection. These were considered to be incidental findings upon medical record review.
Age: 0.2
Sex: F
Vaccine: DTAP, PNC, RV5
Symptoms: Blood culture negative, CSF test normal, Culture urine negative, Electroencephalogram normal, Eye rolling
Clinical narrative: Patient received vaccines 3-21-07 at around 11:30 AM later that day around 6:00PM she started to present shaking of upper and lower extremities: eyes were rolled up lasting approx 5 seconds.  5/22/07 Received hospital medical records which reveal patient experienced fever, possible seizures, suspected sepsis & poor feeding.  Parent reported repeated seizure like activity w/starring, shaking of extremities at home for approx 5 sec.  Admitted 3/21-3/24/07.  Neuro consult done. FINAL DX: possible first seizure.
Age: 0.2
Sex: F
Vaccine: DTAP, PNC, RV5
Symptoms: Full blood count normal, Tremor
Clinical narrative: Patient received vaccines 3-21-07 at around 11:30 AM later that day around 6:00PM she started to present shaking of upper and lower extremities: eyes were rolled up lasting approx 5 seconds.  5/22/07 Received hospital medical records which reveal patient experienced fever, possible seizures, suspected sepsis & poor feeding.  Parent reported repeated seizure like activity w/starring, shaking of extremities at home for approx 5 sec.  Admitted 3/21-3/24/07.  Neuro consult done. FINAL DX: possible first seizure.
Age: 39.0
Sex: M
Vaccine: TYP
Symptoms: Haematocrit normal, Haemoglobin normal, Headache, Hyperreflexia, Leukoencephalomyelitis
Clinical narrative: 41 year old male who reported no problems with his health or prior immunizations until re received the typhoid vaccine on Sat, 5 Feb 2005. He fulfilled his requirements for his drill weekend, although he noted a "wicked" headache on Sun that eased and subsided by Wednesday. He also noted a low grade fever. He did not note any arm soreness or redness and attributed the headache and fever as a normal response to the vaccination. On Sat 12 Feb he noticed dysmetria of his left lower extremity and symptoms worsened to include his left arm. On Mon he sought medical care and reports a positive neuro exam to included decrease sensation, problems with balance and increase reflexes. A MRI revealed 2 small plaques. He was started on steroids and reports a full recovery of all neuro functions by week #3. Subsequent MRI's did not identify any further lesions and he stated he remains asymptomatic. He is however, continuing interferon treatments. He stated he was evaluated at a clinic and they told him that they suspected ADEM and that an evaluation is thinking early MS. He stated he had received oral typhoid in the past with no problems and that he has not received any vaccines since Feb 05. Head pain start: 02/06/2005 End: 02/08/2005, Gait Abnormal Start: 02/12/2005 End: 03/2005, Weakness Start: 02/13/2005 End: 03/2005. Left arm.  04/12/2007 MR received for a single OV of 6/27/2005 for c/o fever, chills, myalgias, and headache which began w/in a few days of receiving his typhoid vax.  Several days later he c/o developing weakness and dysmetria.  Pt. reports that initial PE showed some dysmetria, of upper left  and lower limbs, as well as some clonus and imbalance.  Txd with solumedrol with improvement of physical symptoms.  However some word-finding difficulty remained.  PE: WNL with minimal weakness in the left interossei and ankle dorsiflexors and muslce stretch reflexes are mildly brisk.  Impression:  Clinically isolated CNS inflammatory/demyelinating syndrome, post-vaccination.  Avonex therapy.  04/19/2007 MR received from MS clinic with several OVs from 9/19/2005 to 10/30/2006.  Also included were H&P and D/C Summary from initial hopitalization for AE in 2/2005. H&P dated 02/14/2005 for c/o incoordination, ataxia, and myoclonic jerks x 36 hours.  Myoclonic jerking was noted in the L leg and L arm with associated arm heaviness.   PE showed myoclonic jerking with purposeful movement of the LLE. Biceps DTR 1+.  3+ in quadriceps and  Achilles with myoclonus on the Left. Wavers with Rhomberg, but able to correct self. Wide-based unsteady gait.Slow finger-to-nose on left. Decreased vibratory sensation left foot, otherwise WNL. D/C next day.  DX: MS. F/Us with DX of RRMS. Tx'd with Avonex. No new codes. 04/23/2007 MR received from military facility for 2 OV dated 12/13/2006 and 12/14/2006 for c/o adverse rxn. to Typhoid vax given 2/2005. HPI as above with initial findings suggesting possible MS.  Neurology consult with normal findings. Final DX:  Clinically isolated demyelinating event.
Age: 14.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site swelling, Somnolence
Clinical narrative: Local swelling at injection site to elbow associated with somnolence all vital signs normal occurred within one hour of injection.
Age: 12.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Arthralgia, Dizziness, Hallucination, Nausea, Retching
Clinical narrative: Received shots at 10:30 am-ok until 6:30pm- He was dizzy, nauseous, and had joint pains. 8:30 pm vomiting and then dry heaves. Vision was blurry and he was dizzy. 11 pm he had hallucations, seen in office 4-4-07.
Age: 12.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Vision blurred, Vomiting
Clinical narrative: Received shots at 10:30 am-ok until 6:30pm- He was dizzy, nauseous, and had joint pains. 8:30 pm vomiting and then dry heaves. Vision was blurry and he was dizzy. 11 pm he had hallucations, seen in office 4-4-07.
Age: 13.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Blood pressure decreased, Hyperhidrosis, Pallor, Pharyngolaryngeal pain, Syncope
Clinical narrative: 2-3 min after receiving vaccination while standing had syncopal episode, sweaty, shaking sore throat white lips after 5-10 mins. 12 cups of H2O felt better BP 90/60 BP normal taken prior to exam 106/62 P 80
Age: 13.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Tremor
Clinical narrative: 2-3 min after receiving vaccination while standing had syncopal episode, sweaty, shaking sore throat white lips after 5-10 mins. 12 cups of H2O felt better BP 90/60 BP normal taken prior to exam 106/62 P 80
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Hypotension, Loss of consciousness
Clinical narrative: Passed out in hallway after receiving vaccine. BP 90/30 then elevated to 98/60 took 15 mins to he able to sit up BP normal taken prior to exam 94/60 P 84
Age: 16.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Blood pressure normal, Fall, Heart rate normal, Syncope
Clinical narrative: Syncopal episode appr 5-7 mins after administration of IM Gardasil. Fell at our check out window with no alerts anyone- BP 116/80 BP normal/prior to exam 120/80 P. 92
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Hyperhidrosis, Hypotension, Pallor, Syncope
Clinical narrative: Administered vaccine with on incidents. Suddenly with in 2-3 mins. became faint, sweaty, pale layed pt down on exam table. Responded immediately BP 98/56 AP 68. Observation, cool drink rest no further incidence-discharged with mom (did not drug herself).
Age: 50.0
Sex: M
Vaccine: TDAP
Symptoms: Myalgia, Paraesthesia, Radiculitis brachial
Clinical narrative: Left deltoid my region day after injection. Left arm forearm paresthesias 2 weeks following injection - possible early brachial neuritis.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Pain in extremity, Ultrasound scan
Clinical narrative: Left arm started hurting 3 days after HPV #2 administration. Continued with pain in arm 1 month after administration of shot
Sex: U
Vaccine: DT
Symptoms: Injection site infection
Clinical narrative: Pt developed infectio nat site of vaccine administration. I & D done at ER visit currently undergoing abx rx.
Age: 10.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Pruritus, Swelling
Clinical narrative: 7x5 mm raised, red pruritic reaction R arm warm, itching - not tender. Given Benadryl and observe.
Age: 8.0
Sex: F
Vaccine: IPV, TD
Symptoms: Dizziness, Headache, Heart rate increased, Pallor, Pyrexia
Clinical narrative: Shots given 2/21/07 - mother reports adverse reaction on 4/10/07 - She states pt had rapid heart rate, fever, pale, dizziness, severe headache 2 hrs after injections x 48 hrs took 2 wks for child to return to normal - child did not start immunizations until age 7.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Erythematous, slightly tender swelling on Dtap injection site L deltoid area noted taking.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Swelling, Tooth abscess
Clinical narrative: Marked swelling upper arm 2/3 and redness. Was on Amoxil for teeth abscess
Age: 11.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Pruritus, Rash, Varicella
Clinical narrative: Rash on upper arm with significant itching. Rash not consistent with Varicella.
Age: 38.0
Sex: F
Vaccine: TD
Symptoms: Musculoskeletal pain
Clinical narrative: Shoulder pain
Age: 15.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site is red, swollen, pt states tender to touch. Soft to palpation. Site border marked in pen, warm moist compresses QID.
Age: 0.36
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, RV5, DTAP, HIBV, IPV, PNC, RV5
Symptoms: Fontanelle bulging
Clinical narrative: Mother noticed raised (51) fontanel, 2nd day after imm - no other side effects noticed, per MD (ped) checked baby and didn't seem to think it was imm problem. Mother stated no other problems noticed with baby.
Age: 4.0
Sex: F
Vaccine: VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL
Symptoms: Dyspnoea, Hypersensitivity, Lethargy, Rash
Clinical narrative: Patient developed sneezing and coughing initially after vaccine, then hives around injection site of Varicella L thigh and entire body, with flushes skin then shivering.
Age: 4.0
Sex: F
Vaccine: VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL
Symptoms: Chills, Cough, Dyspnoea, Flushing, Hypersensitivity
Clinical narrative: Patient developed sneezing and coughing initially after vaccine, then hives around injection site of Varicella L thigh and entire body, with flushes skin then shivering.
Age: 4.0
Sex: F
Vaccine: VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL
Symptoms: Hypotension, Injection site urticaria, Lethargy, Rash, Sneezing
Clinical narrative: Patient developed sneezing and coughing initially after vaccine, then hives around injection site of Varicella L thigh and entire body, with flushes skin then shivering.
Age: 4.0
Sex: F
Vaccine: VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL
Symptoms: Urticaria
Clinical narrative: Patient developed sneezing and coughing initially after vaccine, then hives around injection site of Varicella L thigh and entire body, with flushes skin then shivering.
Age: 4.0
Sex: F
Vaccine: VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL
Symptoms: Chills, Cough, Flushing, Injection site urticaria, Sneezing
Clinical narrative: Patient developed sneezing and coughing initially after vaccine, then hives around injection site of Varicella L thigh and entire body, with flushes skin then shivering.
Age: 4.0
Sex: F
Vaccine: VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL
Symptoms: Flushing, Injection site urticaria, Pruritus, Syncope
Clinical narrative: Patient developed sneezing and coughing initially after vaccine, then hives around injection site of Varicella L thigh and entire body, with flushes skin then shivering.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Bacteria stool identified, Carbon dioxide decreased, Culture stool positive, Gastrointestinal haemorrhage, Haematocrit decreased
Clinical narrative: Information has been received from a health professional concerning a 9 week old male, with no medical history and no allergies, who on 23-MAR-2007 was vaccinated with a first 2 ml oral dose of Rotateq (Lot# 655484/1032F). Concomitant vaccines administered on the same day included a dose of IOPL, a dose of COMVAX  (Lot# 655210/1242F) and a dose of PREVNAR. ON 28-MAR-2007 the patient developed rectal bleeding and was taken to the emergency room. The patient was air lifted from the emergency room to the hospital and wad admitted. A small bowel resection was performed on 03-APR-2007. The reporter did not have any additional information about the patient's diagnosis. The patient was placed on antibiotic therapy and at the time of the report was still on life support in critical condition. No product quality complaint was involved. No other information was provided. The reporter also considered the rectal bleeding to be life-threatening and disabling. Lot check have been requested. Additional information has been requested. 60 day Follow-up Information 02-JUL-2007: Pt required surgical resection of small bowel; operative report describes gangrenous bowel (no mention of intussiception) and peritonitis. Post-operative report does not comment on etiology of ischemic/gangrenous bowel.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Haemoglobin decreased, Heart rate increased, Intensive care, Intestinal resection, Intussusception
Clinical narrative: Information has been received from a health professional concerning a 9 week old male, with no medical history and no allergies, who on 23-MAR-2007 was vaccinated with a first 2 ml oral dose of Rotateq (Lot# 655484/1032F). Concomitant vaccines administered on the same day included a dose of IOPL, a dose of COMVAX  (Lot# 655210/1242F) and a dose of PREVNAR. ON 28-MAR-2007 the patient developed rectal bleeding and was taken to the emergency room. The patient was air lifted from the emergency room to the hospital and wad admitted. A small bowel resection was performed on 03-APR-2007. The reporter did not have any additional information about the patient's diagnosis. The patient was placed on antibiotic therapy and at the time of the report was still on life support in critical condition. No product quality complaint was involved. No other information was provided. The reporter also considered the rectal bleeding to be life-threatening and disabling. Lot check have been requested. Additional information has been requested. 60 day Follow-up Information 02-JUL-2007: Pt required surgical resection of small bowel; operative report describes gangrenous bowel (no mention of intussiception) and peritonitis. Post-operative report does not comment on etiology of ischemic/gangrenous bowel.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Lethargy, Livedo reticularis, Red blood cell count decreased, Surgery, Swelling
Clinical narrative: Information has been received from a health professional concerning a 9 week old male, with no medical history and no allergies, who on 23-MAR-2007 was vaccinated with a first 2 ml oral dose of Rotateq (Lot# 655484/1032F). Concomitant vaccines administered on the same day included a dose of IOPL, a dose of COMVAX  (Lot# 655210/1242F) and a dose of PREVNAR. ON 28-MAR-2007 the patient developed rectal bleeding and was taken to the emergency room. The patient was air lifted from the emergency room to the hospital and wad admitted. A small bowel resection was performed on 03-APR-2007. The reporter did not have any additional information about the patient's diagnosis. The patient was placed on antibiotic therapy and at the time of the report was still on life support in critical condition. No product quality complaint was involved. No other information was provided. The reporter also considered the rectal bleeding to be life-threatening and disabling. Lot check have been requested. Additional information has been requested. 60 day Follow-up Information 02-JUL-2007: Pt required surgical resection of small bowel; operative report describes gangrenous bowel (no mention of intussiception) and peritonitis. Post-operative report does not comment on etiology of ischemic/gangrenous bowel.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Gangrene, Life support, Peritonitis, Rectal haemorrhage, Small intestinal resection
Clinical narrative: Information has been received from a health professional concerning a 9 week old male, with no medical history and no allergies, who on 23-MAR-2007 was vaccinated with a first 2 ml oral dose of Rotateq (Lot# 655484/1032F). Concomitant vaccines administered on the same day included a dose of IOPL, a dose of COMVAX  (Lot# 655210/1242F) and a dose of PREVNAR. ON 28-MAR-2007 the patient developed rectal bleeding and was taken to the emergency room. The patient was air lifted from the emergency room to the hospital and wad admitted. A small bowel resection was performed on 03-APR-2007. The reporter did not have any additional information about the patient's diagnosis. The patient was placed on antibiotic therapy and at the time of the report was still on life support in critical condition. No product quality complaint was involved. No other information was provided. The reporter also considered the rectal bleeding to be life-threatening and disabling. Lot check have been requested. Additional information has been requested. 60 day Follow-up Information 02-JUL-2007: Pt required surgical resection of small bowel; operative report describes gangrenous bowel (no mention of intussiception) and peritonitis. Post-operative report does not comment on etiology of ischemic/gangrenous bowel.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Intussusception, Small intestinal resection
Clinical narrative: Information has been received from a health professional concerning a 9 week old male, with no medical history and no allergies, who on 23-MAR-2007 was vaccinated with a first 2 ml oral dose of Rotateq (Lot# 655484/1032F). Concomitant vaccines administered on the same day included a dose of IOPL, a dose of COMVAX  (Lot# 655210/1242F) and a dose of PREVNAR. ON 28-MAR-2007 the patient developed rectal bleeding and was taken to the emergency room. The patient was air lifted from the emergency room to the hospital and wad admitted. A small bowel resection was performed on 03-APR-2007. The reporter did not have any additional information about the patient's diagnosis. The patient was placed on antibiotic therapy and at the time of the report was still on life support in critical condition. No product quality complaint was involved. No other information was provided. The reporter also considered the rectal bleeding to be life-threatening and disabling. Lot check have been requested. Additional information has been requested. 60 day Follow-up Information 02-JUL-2007: Pt required surgical resection of small bowel; operative report describes gangrenous bowel (no mention of intussiception) and peritonitis. Post-operative report does not comment on etiology of ischemic/gangrenous bowel.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Bacteria stool identified, Carbon dioxide decreased, Gastrointestinal haemorrhage, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Information has been received from a health professional concerning a 9 week old male, with no medical history and no allergies, who on 23-MAR-2007 was vaccinated with a first 2 ml oral dose of Rotateq (Lot# 655484/1032F). Concomitant vaccines administered on the same day included a dose of IOPL, a dose of COMVAX  (Lot# 655210/1242F) and a dose of PREVNAR. ON 28-MAR-2007 the patient developed rectal bleeding and was taken to the emergency room. The patient was air lifted from the emergency room to the hospital and wad admitted. A small bowel resection was performed on 03-APR-2007. The reporter did not have any additional information about the patient's diagnosis. The patient was placed on antibiotic therapy and at the time of the report was still on life support in critical condition. No product quality complaint was involved. No other information was provided. The reporter also considered the rectal bleeding to be life-threatening and disabling. Lot check have been requested. Additional information has been requested. 60 day Follow-up Information 02-JUL-2007: Pt required surgical resection of small bowel; operative report describes gangrenous bowel (no mention of intussiception) and peritonitis. Post-operative report does not comment on etiology of ischemic/gangrenous bowel.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Heart rate increased, Intussusception, Lethargy, Life support, Livedo reticularis
Clinical narrative: Information has been received from a health professional concerning a 9 week old male, with no medical history and no allergies, who on 23-MAR-2007 was vaccinated with a first 2 ml oral dose of Rotateq (Lot# 655484/1032F). Concomitant vaccines administered on the same day included a dose of IOPL, a dose of COMVAX  (Lot# 655210/1242F) and a dose of PREVNAR. ON 28-MAR-2007 the patient developed rectal bleeding and was taken to the emergency room. The patient was air lifted from the emergency room to the hospital and wad admitted. A small bowel resection was performed on 03-APR-2007. The reporter did not have any additional information about the patient's diagnosis. The patient was placed on antibiotic therapy and at the time of the report was still on life support in critical condition. No product quality complaint was involved. No other information was provided. The reporter also considered the rectal bleeding to be life-threatening and disabling. Lot check have been requested. Additional information has been requested. 60 day Follow-up Information 02-JUL-2007: Pt required surgical resection of small bowel; operative report describes gangrenous bowel (no mention of intussiception) and peritonitis. Post-operative report does not comment on etiology of ischemic/gangrenous bowel.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Rectal haemorrhage, Red blood cell count decreased, Small intestinal resection, Stool analysis abnormal, Swelling
Clinical narrative: Information has been received from a health professional concerning a 9 week old male, with no medical history and no allergies, who on 23-MAR-2007 was vaccinated with a first 2 ml oral dose of Rotateq (Lot# 655484/1032F). Concomitant vaccines administered on the same day included a dose of IOPL, a dose of COMVAX  (Lot# 655210/1242F) and a dose of PREVNAR. ON 28-MAR-2007 the patient developed rectal bleeding and was taken to the emergency room. The patient was air lifted from the emergency room to the hospital and wad admitted. A small bowel resection was performed on 03-APR-2007. The reporter did not have any additional information about the patient's diagnosis. The patient was placed on antibiotic therapy and at the time of the report was still on life support in critical condition. No product quality complaint was involved. No other information was provided. The reporter also considered the rectal bleeding to be life-threatening and disabling. Lot check have been requested. Additional information has been requested. 60 day Follow-up Information 02-JUL-2007: Pt required surgical resection of small bowel; operative report describes gangrenous bowel (no mention of intussiception) and peritonitis. Post-operative report does not comment on etiology of ischemic/gangrenous bowel.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, HIBV, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Abdominal pain, Haematochezia, Muscle spasms, Surgery, Vomiting
Clinical narrative: she had the rotavirus vaccine given to her on  04/04/2007 then the following day she started throwing up and continued to every ten to twenty minutes an could not sleep so i called the doctor and he said she probably had the stomach flu and should last a day or two. Later that night she pooped so i changed her and her diaper was completely filled with blood. so my mom an i rushed her to the emergency room and through x rays found out that she had her bowels clogged so she was transferred in a ambulance to a better hospital were they had to take out some of her intestine and collin. she stayed in the hospital for 5 days. I guess it is called intussusception.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, HIBV, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Gastroenteritis viral, Haematochezia, Insomnia, Intestinal obstruction, Intestinal resection
Clinical narrative: she had the rotavirus vaccine given to her on  04/04/2007 then the following day she started throwing up and continued to every ten to twenty minutes an could not sleep so i called the doctor and he said she probably had the stomach flu and should last a day or two. Later that night she pooped so i changed her and her diaper was completely filled with blood. so my mom an i rushed her to the emergency room and through x rays found out that she had her bowels clogged so she was transferred in a ambulance to a better hospital were they had to take out some of her intestine and collin. she stayed in the hospital for 5 days. I guess it is called intussusception.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, HIBV, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Intussusception, Sleep disorder, Vomiting, X-ray abnormal
Clinical narrative: she had the rotavirus vaccine given to her on  04/04/2007 then the following day she started throwing up and continued to every ten to twenty minutes an could not sleep so i called the doctor and he said she probably had the stomach flu and should last a day or two. Later that night she pooped so i changed her and her diaper was completely filled with blood. so my mom an i rushed her to the emergency room and through x rays found out that she had her bowels clogged so she was transferred in a ambulance to a better hospital were they had to take out some of her intestine and collin. she stayed in the hospital for 5 days. I guess it is called intussusception.